Somatostatin receptor agonist, derived from the post-translational cleavage of prosomatostatin.

Alclofenac has a significant effect on the acute phase protein response and the degree of L-tryptophan binding to plasma protein and can be used in the treatment of patients with chronic rheumatism.

2''-O-Rhamnosylicariside II is beneficial for improving postmenopausal osteoporosis. It shows potent antioxidant activity, with IC50 values of 90.5 uM.